Related Experiment Videos

Adenosine-sensitive ventricular tachycardia. Clinical characteristics and response to catheter ablation

D J Wilber1, J Baerman, B Olshansky

  • 1Section of Cardiology, Loyola University Medical Center, Maywood, Ill 50153.

Circulation
|January 1, 1993
PubMed
Abstract

Insights

Adenosine-sensitive ventricular tachycardia, often occurring during exertion, originates from the pulmonary infundibulum. Catheter ablation provides a long-term cure for this condition in patients without structural heart disease.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Medical Devices

Background:

  • Sustained ventricular tachycardia (VT) without structural heart disease can stem from various mechanisms.
  • Adenosine's ability to terminate VT suggests triggered automaticity as a common cause.
  • This study investigates the characteristics and treatment of such VT patients.

Purpose of the Study:

  • To examine the clinical features of adenosine-sensitive VT.
  • To understand electrophysiological responses to programmed stimulation.
  • To evaluate the efficacy of catheter ablation for this specific VT type.

Main Methods:

  • Adenosine administration to terminate VT.
  • Programmed ventricular stimulation to induce VT.
  • Signal-averaged ECGs and myocardial scintigraphy (123I-metaiodobenzylguanidine) for diagnostics.
  • Catheter ablation using direct current shocks or radiofrequency energy.

Main Results:

  • Adenosine terminated VT in 7/14 patients lacking structural heart disease.
  • VT presented with LBBB, inferior axis, and was linked to stress/exertion.
  • A discrete origin in the pulmonary infundibulum free wall was identified in all cases.
  • Catheter ablation achieved long-term VT abolition in all treated patients.

Conclusions:

  • Adenosine-sensitive VT originates from discrete sites, primarily the pulmonary infundibulum free wall.
  • The localized nature of this VT makes it highly curable with catheter ablation.
  • Catheter ablation offers a definitive treatment option for this patient subgroup.

Related Concept Videos